Israeli and Emirati companies ink deal to jointly research COVID-19 technology

An Emirati company and an Israeli firm sign a strategic commercial agreement to jointly research and develop technology in the fight against the coronavirus.

APEX National Investment, of the UAE, and Israel’s TeraGroup sign the deal at a press conference in Abu Dhabi, according to the Emirati news agency WAM.

The two companies will work on developing a COVID-19 testing device to more quickly and accurately diagnose the disease.

TeraGroup is developing a COVID-19 testing device that aims to detect the disease in a patient’s breath and deliver results in one minute.

It wasn’t immediately clear if this project was part of the joint agreement with APEX.

Israel and the UAE signed a historic normalization agreement on Thursday, which included developing commercial ties between the two countries.

The two states have been quietly cooperating on their response to the coronavirus for months, which played a part in moving the normalization agreement forward, according to Friday reports.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.